<DOC>
	<DOCNO>NCT01887184</DOCNO>
	<brief_summary>Upper gastrointestinal endoscopy , like many diagnostic therapeutic procedure , may associate discomfort . Although upper endoscopy usually short duration well tolerated patient , trial investigate influence analgesia sedation perform patient undergoing procedure . Some patient may tolerate colonoscopy without sedation , various technique use limit discomfort pain . Selection dose sedative depend patient 's emotional state , intensity pain examination , foreseeable technical difficulty , endoscopist 's experience , presence absence anesthesia personnel , hospital-specific procedure . Conscious sedation popular technique colonoscopy upper gastrointestinal endoscopy . The combination opioid benzodiazepine know provide good analgesic sedative condition endoscopy . This combination opioid benzodiazepine , however , also increase risk respiratory depression . Therefore , pharmacologic agent may provide adequate sedation without respiratory depression great interest clinician . Dexmedetomidine highly selective α2-adrenoceptor agonist sedative analgesic effect . Compared clonidine , selective α 2 adrenoceptor act full agonist pharmacologic test model . Potentially desirable property include decreased requirement anesthetic analgesic , diminish sympathetic response stress potential cardioprotective effect myocardial ischemia . When compare conventional sedative opioids benzodiazepine , lack respiration depression distinct advantage . Previous study use dexmedetomidine sedation promise maintenance respiratory function . Patients readily arousable . With intravenous slow bolus administration , minimal increase blood pressure initially , follow slight decrease blood pressure . Lower dose range , avoidance rapid bolus injection , slow rate administration tend decrease circulatory side effect . Many clinical study show well safely use intravenously , intramuscularly transdermally . Although officially technique , also report intranasal administration result fairly predictable onset adult child .</brief_summary>
	<brief_title>Sedation Using Intranasal Dexmedetomidine Upper Gastrointestinal Endoscopy</brief_title>
	<detailed_description>Aims : This study aim evaluate sedative effect use intranasal dexmedetomidine upper gastrointestinal endoscopy . The investigator aim evaluate efficacy , side effect acceptability sedation use intranasal dexmedetomidine patient endoscopist upper gastrointestinal endoscopy . Methods : Double blind randomized prospective study . Sample size : We plan detect le 30 % decrease rescue propofol consumption use intranasal dexmedetomidine . Assuming average propofol consumption upper gastrointestinal endoscopy 40mg SD=15mg , require sample size 80 % power test 25 per group 0.05 level significance . They randomly allocate one follow study group : Group D : Intranasal dexmedetomidine 1.5mcg/kg ; Group P : Intranasal saline ( placebo ) In addition , rescue sedation provide patient-controlled sedation use propofol/ alfentanil group . Patient-controlled sedation ( PCS ) show provide safe effective sedation individual patient allow patient decide whether require sedation determine amount require . PCS use various procedure perform local regional anesthesia . PCS propofol alfentanil use sedation patient endoscopy . Process Written consent sign . No sedative premedication prescribe . The patient fast 6 hour procedure . Then patient send endoscopy room 1 hour procedure . A nasal catheter position deliver oxygen oxygen need . Vital sign include heart rate , blood pressure , SpO2 respiratory rate record . After obtain baseline hemodynamic data ( NIBP , HR ) respiratory data ( SpO2 , RR ) , patient ask evaluate baseline level anxiety use numerical rating scale . The intranasal study drug administrate accord code piece fold paper drawn randomly box . The patient randomly allocate one two treatment group sedation perform 1 hour procedure follow : P ) Placebo ( 0.015ml/kg ) ; D ) Intranasal dexmedetomidine 0.015ml/kg Before study drug administration , patient gently blow nose . After baseline testing , investigator blind study medication administers study drug naris patient remain semi-recumbent position head bed elevated 20-40 angle . After , measurement include HR , NiBP , SpO2 , RR record every 5 minute Numerical Rating Scale anxiety every 15 minute . Sedation evaluate investigator use Observer Assessment Alertness/ Sedation ( OAA/S ] ) scale every 15 minute . Both investigator subject blind study medication . The patient show 2 card picture 1 hour study drug administration . An intravenous cannula insert . The degree cannulation pain assess use NRSpaincannulation . The intravenous cannula connect 50 mL syringe patient-controlled analgesia pump contain 200 mg ( 20 mL ) propofol 0.5 mg ( 1 mL ) alfentanil , provide rescue sedative medication . The drug deliver response pressure hand-held button . Each bolus dose 0.5 mL deliver contain 4.8 mg propofol 12 μg alfentanil . No load dose use lock time set zero . Despite zero lock time , second require pump deliver preset bolus . The PCA pump program deliver bolus dose 0.5 ml 200 ml/h patient 's demand pump take 9 deliver bolus , time would respond demand . Thus , effective lockout time 9 . Patients instructed use hand-held button upper endoscopy . After cannulation , local anesthetic spray administer oropharynx rectum . 10 minute local anesthesia , patient may start push button . When first dose propofol alfentanil infuse , patient ask whether pain infusion , degree pain assess Numerical Rating Scale pain due infusion . The procedure start patient feel relaxed . Vital sign include NIBP , SpO2 , HR , RR , OAA/S monitor throughout sedation procedure process every 5 minute . If patient becomes totally unresponsive adverse event occurs , procedure stop . If SpO2 fall 90 % 10 second , endoscope remove patient 's vital sign observe , O2 administer require attend anesthesiologist patient become responsive . Once patient start respond command , procedure continue . Duration unresponsiveness would record . The time start procedure duration procedure frequencies interruption due patient event note . The PCS propofol alfentanil terminate disconnected patient endoscopist indicate operative procedure complete , dose consumption record . The endoscopist determine operate condition evaluate ease insertion patient 's lack motion ability obey command , use NRSsatisfactionendoscopist . The patient transfer recovery room monitoring 30 minute . The vital sign ( blood pressure , pulse , RR SpO2 , OAA/S ) continue every 5 min . When patient fully recover , ask pain discomfort severity assess NRSpain NRSdiscomfort procedure . Discomfort define ' feel uneasiness interfered patient 's ability relax ' . They also ask remember following event : picture show , insertion endoscope , discomfort pain examination . Discharge criterion assess postanaesthesia discharge score hourly . When patient fully recover , define OAA/S score 5 postanaesthesia score 9 , fit discharge . Satisfaction evaluation sedation grade patient NRS satisfaction patient . They question whether think receive adequate amount sedation , little much , whether relaxed whether undergo procedure . Data Collection 1 . Demographic data 2 . Type endoscopy 3 . Duration sedation 4 . Duration procedure 5 . Duration recovery area 6 . Duration end procedure become fully awake 7 . Duration general ward discharge 8 . Pain severity ( NRS pain ) cannulation , infused propofol alfentanil , examination 9 . Vital sign sedation , procedure Postoperatively ( HR , NIBP , SpO2 , RR ) 10 . OAA/S administration , procedure 11 . NRSpain NRSdiscomfort administration , procedure 12 . Time OAA/S 4 13 . Tries good propofol alfentanil procedure 14 . Propofol alfentanil consumption 15 . NRSsatisfactionendoscopist 16 . NRSsatisfactionpatient 17 . Adverse event severity intraoperatively postoperatively include oversedation , respiratory depression , hypotension , paradoxical reaction , dizziness , nausea vomiting , bradycardia . The severity adverse event grade follow : Mild : treatment Moderate : require treatment Severe : refractory treatment Data Analysis Student test , Mann-Whitney U test Chi-square test apply analysis . Study Duration : 18 month . Provide data current case load upper endoscopy Queen Mary Hospital .</detailed_description>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>American Society Anesthesiology grade IIII 1860 year old Patients upper endoscopy Clinical history electrocardiographic evidence heart block , ischaemic heart disease , asthma , sleep apnoea syndrome BMI &gt; 35kg/m2 Impaired liver ( preoperative serum albumin level le 30g/L ) renal function ( creatinine &gt; 120umol/L ) ) know renal hepatic disease Alcohol consumption excess 28 unit per week Pregnancy Patient refusal Known psychiatric illness Chronic sedative use , regular use know allergy dexmedetomidine , propofol opioids .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>